Circular dichroism in the study of stereoselective binding of drugs to serum proteins

Chemical Analysis

Volumn 142, Issue , 1997, Pages 521-543

  Bertucci, Carlo ^a   Salvadori, Piero ^a   Domenici, Enrico ^b  

^a UNIVERSITY OF PISA   (Italy)

^b GSK   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0345910465     PISSN: 00692883     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (74)

1. Anton, A. H. and Solomon, H. M (eds.) (1973). Drug-protein binding. Annals of the New York Academy of Science, Vol. 226.
2. Vallner, J. J. (1977). Binding of drugs by albumin and plasma proteins. J. Pharm. Sci., 66: 447-65.
3. Tillement, J. P., Houin, G., Zini, R., Urien, S., Albengres, E., Barré, J., Lecompte, M., D'Athis, P., and Sebille, B. (1984). The binding of drugs to blood plasma macromolecules: Recent advances and therapeutic significance. In B. Testa (ed.), Advances in Drug Research, Vol. 13. London: Academic Press, pp. 59-94.
4. Levy, R. and Shand, D. (eds.) (1984). Clinical implications of drug-protein binding. Clin. Pharmacokin., 9 (suppl. 1), 1-104.
5. Fichtl, B., Nieciecki, A., and Walter, K. (1991). Tissue binding of drugs: General principles and pharmacokinetic consequences. In B. Testa (ed.), Advances in Drug Research, Vol. 20. London: Academic Press, pp. 118-166.
6. Stereochemistry and Biological Activity of Drugs. Ariens. E. J., Soudijn, W., and Timmermans, P. B. M. W. M. (eds.) (1983). London: Blackwell.
7. Simonyi, M. (1984). On chiral drug action. Med. Res. Rev., 4, 359-413.
8. Wainer, I. W. (Ed.). 2nd ed. (1993). Drug Stereochemistry: Analytical Methods and Pharmacology. New York: Marcel Dekker.
9. Jamali, J., Mehvar, R., and Pasutto, F. M. (1989). Enantioselective aspects of drugs action and disposition: Therapeutic pitfalls. J. Pharm. Sci., 7, 695-715.
10. Holmstedt, B., Frank, A., and Testa, B. (eds.) (1990). Chirality and Biological Activity. New York: Alan R. Liss.
11. Caldwell, J. (1992). The importance of stereochemistry in drug action and disposition. J. Clin. Pharmacol., 32, 925-929.
12. Kragh-Hansen, U. (1981) Molecular aspects of ligand binding to serum albumin. Pharmacol. Rev., 33, 17-53.
13. Kremer, J. M. H., Wilting, J., and Janssen, L. H. M. (1988). Drug binding to human alpha-1-acid glycoprotein in health and disease. Pharmacol. Rev., 40, 1-47.
14. Noctor, T. A. G. (1993). In Wainer I. W. (ed.), Drug Stereochemistry: Analytical Methods and Pharmacology, 2nd ed. New York: Marcel Deker, pp. 337-364.
15. Müller, W. E. and Wollert, U. (1975). High stereospecificity of the benzodiazepine binding site on human serum albumin. Mol. Pharmacol., 11, 52-60.
16. Müller, W. E. and Wollert, U. (1979). Human serum albumin as a silent receptor for drugs and endogeneous substances. Pharmacology, 19, 59-68.
17. Sudlow, G., Birkett, D. J., and Wade, D. N. (1975). The characterisation of two drug specific binding sites on human serum albumin. Mol. Pharmacol., 11, 824-832.
18. Kragh-Hansen, U. (1990). Structure and ligand binding properties of human serum albumin. Danish Med. Bull., 37, 57-84.
19. He, X. M. and Carter, D. C. (1992). Atomic structure and chemistry of human serum albumin. Nature, 358, 209-215.
20. Carter, D. C. and Ho, J. X. (1994). Structure of serum albumin. Adv. Protein. Chem., 45, 153-203.
21. Fehske, K. J., Müller, W. E., and Wollert, U. (1981). The location of drug binding sites in human serum albumin. Biochem. Pharmacol., 30, 687-692.
22. Honorè, B. and Brodersen, R. (1984). Albumin binding of anti-inflammatory drugs. Utility of a site-oriented versus a stoichiometric analysis. Mol. Pharmacol., 35, 137-150.
23. Walji, R., Rosen, A., and Hider, R. C. (1993). The existence of conformationally labile (preformed) drug binding sites in human serum albumin as evidenced by optical rotation measurements. J. Pharm. Pharmacol., 45, 551-558.
24. Sebille, B. (1990). Methods of drug protein binding determination. Fund. Clin. Pharmacol., 4 (suppl.) 2, 151-161.
25. Pacifici, G. M. and Viani, A. (1992). Methods of determining plasma and tissue binding of drugs. Clin. Pharmacokinet., 23, 449-468.
26. Sebille, B., Zini, R, Madjar, C. V., Thuaud, N., and Tillement, J. P. (1990). Separation procedures used to reveal and follow drug protein binding. J. Chromatogr., 531, 51-77.
27. Chignell, C. F. (1968). Circular dichroism studies of drug-protein complexes. Life Sci., 7, 1181-1186.
28. Rosen, A. (1970). The measurement of binding constants using circular dichroism. Binding of phenylbutazone and oxyphenbutazone. Biochem. Pharmacol., 19, 2075-2081.
29. Sjöholm, I. and Sjödin, T. (1972). Binding of drugs to human serum albumin. I. Circular dichroism studies on the binding of some analgesics, sedatives and antidepressive agents. Biochem.Pharmacol., 21, 3041-3052.
30. Blauer, G., Harmatz, D., and Snir, J. (1972). Optical properties of bilirubin-serum albumin complexes in aqueous solution. I. Dependence on pH. Biochim. Biophys. Acta, 278, 68-88.
31. Müller, W. E. and Wollert, U. (1973). Interaction of benzodiazepines with human serum albumin. Circular dichroism studies. Naunyn-Schmiedeberg's Arch. Pharmacol., 278, 301-312.
32. Perrin, J. H. and Nelson, D. A. (1973). Competitive binding of two drugs for a single binding site on albumin: a circular dichroic study. J. Pharm. Pharmacol., 25, 125-130.
33. Müller, W. E. and Wollert, U. (1974). Influence of pH on the benzodiazepine-human serum albumin complex. Circular dichroism study. Naunyn Schmiedeberg's Arch. Pharm., 283, 67-82.
34. Perrin, J. H., Vallner, J. J., and Nelson, D. A. (1975). Some quantitative investigations of the binding to and the displacement of bishydroxycoumarin from human serum albumin. Biochem. Pharmacol., 24, 769-774.
35. Blauer, G. and Wagnière, G. (1975). Conformation of bilirubin and biliverdin in their complexes with serum albumin. J. Am. Chem. Soc., 97, 1949-1954.
36. Sjödin, T., Roosdorp, N., and Sjöholm, I. (1976). Studies on the binding of benzodiazepines to human serum albumin by circular dichroism measurements. Biochem. Pharmacol., 25, 2131-2140.
37. Roodsorp, N. and Sjöholm, I. (1976). Determination of binding constants from continuous circular dichroism titration data by numerical analysis. Biochem. Pharmacol., 25, 2141-2145.
38. Brown, N. A., Jähnchen, E., Müller, W. E., and Wollert, U. (1977). Optical studies on the mechanism of the interaction of the enantiomers of the anticoagulant drugs phenprocoumon and warfarin to human serum albumin. Mol. Pharmacol., 13, 70-79.
39. Brodersen, R., Sjödin, T., and Sjöholm, I. (1977). Independent binding of ligands to human serum albumin. J. Biol. Chem., 252, 5067-5072.
40. Alebic-Kolbah, T., Kajfez, F., Rendic, S., Sunjic, V., Konowal, A., and Snatzke, G. (1979). Circular dichroism and gel filtration studies of binding of prochiral and chiral 1,4-benzodiazepin-2-ones to human serum albumin. Biochem. Pharmacol., 28, 2457-2464.
41. Konowal, A., Snatzke, G., Alebic-Kolbah, T., Kajfez, F., Rendic, S., Sunjic, V. (1979). General approach to chiroptical characterization of binding of prochiral and chiral 1,4-benzodiazepin-2-ones to human serum albumin. Biochem. Pharmacol., 28, 3109-3113.
42. Wilting, J. T., Hart, B. J., and De Gier, J. J. (1980). The role of albumin conformation in the binding of diazepam to human serum albumin. Biochim. Biophvs. Acta, 626, 291-298.
43. Wilting, J., van der Giesen, W. F., Janssen, L. H. M. Weideman, M. M., Otagiri, M., and Perrin, J. H. (1980). The effect of albumin conformation on the binding of warfarin to human serum albumin. J. Biol. Chem., 255, 3032-3037.
44. Honoré, B. and Frandsen, P. C. (1986). Conformational changes in the bilirubin-serum albumin complex at extreme alkaline pH. Biochem. J., 236, 365-369.
45. Fitos, I., Simonyi, M., Tegyey, Z., Kajtar, M., and Ötvös, L. (1986) Binding of 3-alkyl-1,4-benzodiazepin-2-one stereoisomers to human serum albumin. Arch. Pharm., (Weinheim) 319, 744-749.
46. Otagiri, M., Maruyama, T., Imai, T., Suenaga, A., and Imamura, Y. A. (1987). A comparative study of the interaction of warfarin with human α1-acid glycoprotein and human albumin. J. Pharm. Pharmacol., 39, 416-420.
47. Honoré, B., Sato, H., and Brodersen, R. (1988). Cobinding of bilirubin and laurate to human serum albumin: spectroscopic characterization of stoichiometric complexes. Arch. Biochem. Biophys., 266, 189-196.
48. Otagiri, M., Yamamichi, R., Maruyama, T., Imai, T., Suenaga, A., Imamura, Y., and Kimachi, K. (1989). Drug binding to α1-acid glycoprotein studied by circular dichroism. Pharm. Res., 6, 156-159.
49. 1-acid glycoprotein. Biochem. Pharmacol., 38, 2259-2262.
50. Bertucci, C., Domenici, E., and Salvadori, P. (1990). Stereochemical features of 1,4-benzodiazepin-2-ones bound to human serum albumin: difference CD and UV studies. Chirality 2, 167-174.
51. Oravcová, J., Mlynárik, V., Bystrickỳ, S., Šoltès, L., Szalay, P., Bohácik, L., and Trnovec, T. (1991). Interaction of pirprofen enantiomers with human serum albumin. Chirality, 3, 412-417.
52. Rahman, M. H., Maruyama, T., Okada, T., Yamasaki, K., and Otagiri, M. (1993). Study of interaction of carprofen and its enantiomers with human serum albumin. I. Mechanism of binding studied by dialysis and spectroscopic methods. Biochem. Pharmacol., 46, 1721-1731.
53. Rahman, M. H., Maruyama, T., Okada, T., Imai, T., and Otagiri, M. (1993). Study of interaction of carprofen and its enantiomers with human serum albumin. II. Stereoselective site-to-site displacement of carprofen by ibuprofen. Biochem. Pharmacol., 46, 1733-1740.
54. Brittain, H. G. and Purdie, N. (ed.) (1994). Analytical Application of Circular Dichroism., New York: Elsevier Science B.V.
55. Ascoli, G., Bertucci, C., and Salvadori, P. (1995). Stereospecific and competitive binding of drugs to human serum albumin: A difference circular dichroism approach. J. Pharm. Sci., 84, 737-741.
56. Bertucci, C., Viegi, A., Ascoli, G., Salvadori, P. (1995). Protein binding investigation by difference circular dichroism: Native and acetylated human serum albumins. Chirality, 7, 57-61.
57. Nakanishi, K., Berova, N., and Woody, R. W. (eds.) (1994). Circular Dichroism, Principles and Applications. New York: VCH.
58. Sunjic, V., Lisini, A., Sega, A, Kovac, T., and Kajfez, F. (1979). Conformation of 7-chloro-5-phenyl-3(S)-methyl-dihydro-1,4-benzodiazepin-2-one in solution. J. Heterocyclic Chem., 16, 757-761.
59. Domenici, E., Bertucci, C., Salvadori, P., Motellier, S., and Wainer, I. W. (1990). Immobilized serum albumin: Rapid HPLC probe of stereoselective protein binding interactions. Chirality, 2, 167-174.
60. Benesi, H. and Hildebrand, J. H. (1949). A spectrophotometric investigation of iodine with aromatic hydrocarbons. J. Amer. Chem. Soc., 71, 2703-2707.
61. MacKichan, J. J. (1984). Pharmacokinetic consequences of drug displacement from blood and tissue proteins. Clin. Phamacokin., 9 (suppl. 1), 32-41.
62. McElnay, D. C. and DeArcy, P. F. (1983). Protein binding displacement interactions and their clinical importance. Drugs, 25, 495-513.
63. Goodman Gilman, A., Rall, T. W., Nies, A. S., and Taylor, P. (eds.) (1991). The Pharmacological Basis of Therapeutics., New York: Pergamon, Chap. 55, p. 1320.
64. Honoré, B. (1990). Conformational changes in human serum albumin induced by ligand binding. Pharmacol. Toxicol., 66 (suppl. II), 1-26.
65. Wainer, I. W. (1994). Enantioselective high performance liquid affinity chromatography as a probe of ligand-biopolymer interactions: An overview of a different use for high performance liquid chromatographic chiral stationary phases. J. Chromatogr., 666, 221-234.
66. Noctor, T. A. G., Pham, C. D., Kaliszan, R., and Wainer, I. W. (1992). Stereochemical aspects of benzodiazepine binding to human serum albumin. I. Enantioselective high performance liquid affinity chromatography examination of chiral and achiral binding interactions between 1,4-benzodiazepines and human serum albumin. Mol. Pharmacol., 42, 506-511.
67. Sudlow, G., Birkett, D. J., and Wade, N. (1976). Further characterization of specific drug binding sites on human serum albumin. Mol. Pharmacol., 12, 1052-1061.
68. Maruyama, K., Nishigori, H., and Iwatsuru, M. (1985). Characterization of the benzodiazepine binding site (diazepam site) on human serum albumin. Chem. Pharm. Bull., 33, 5002-5012.
69. Farr, R. S., Reid, R. T., and Minden, P. (1966). Spontaneous and induced alterations in the anion binding properties of human albumin. J. Clin. Invest., 45, 1006-1012.
70. Walker, J. E. (1976). Lysine residue 199 of human serum albumin is modified by acetylsalicylic acid. FEBS Lett., 66, 173-175.
71. Shaklay, N., Garlick, R. L., and Bunn, H. F. (1984). Non-enzymatic glycosylation of human serum albumin alters its conformation and function. J. Biol. Chem., 259, 3812-3817.
72. Iberg, N. and Flückiger, R. (1986). Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites. J. Biol. Chem., 261, 13542-13545.
73. Okabe, N. and Hashizume, N. (1994). Drug binding properties of glycosylated human serum albumin as measured by fluorescence and circular dichroism. Biol. Pharm. Bull., 17, 16-21.
74. Woody, R. W. (1994). In Nakanishi, K., Berova, N., and Woody, R. W. (eds.) Circular Dichroism, Principles and Applications. New York: VCH Publ., pp. 473-496 (and references there).